Search Results for keywords:"Confidential Disclosure Agreement"

Found 2 results
Skip to main content

Search Results: keywords:"Confidential Disclosure Agreement"

  • Type:Notice
    Citation:86 FR 9520
    Reading Time:about 2 minutes

    The National Institutes of Health (NIH) is announcing the availability of a government-owned invention for licensing. This invention involves monoclonal antibodies that can neutralize Epstein-Barr virus (EBV), which causes infectious mononucleosis and various cancers. These antibodies offer potential uses in diagnostics, therapeutics, and vaccine research. Interested parties can contact Peter Soukas for licensing opportunities or collaborative research to further develop and commercialize this technology.

    Simple Explanation

    The NIH has a special tool that can help fight a virus that makes people sick and can also lead to cancer. They are looking for people who want to work with them to test and use this tool to help others.

  • Type:Notice
    Citation:86 FR 12007
    Reading Time:about 2 minutes

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), announced that certain government-owned inventions are available for licensing. One such invention involves the use of statins, like atorvastatin, to prevent hearing loss caused by chemotherapy drugs like cisplatin. Hearing loss is a common side effect for many cancer patients undergoing treatment, and statins are being explored to mitigate this issue. The announcement highlights both the potential applications for these statins in preventing hearing loss and the readiness of the technology for commercial development.

    Simple Explanation

    The government has some cool ideas, like using certain medicines to help people not lose their hearing during cancer treatment, and they're looking for people or companies to help make these ideas real and useful for everyone.